Zantac Cancer Risk and Lawsuits
On April 1, 2020, the U.S. Food and Drug Administration (FDA) announced that manufacturers should immediately pull all prescription Zantac and over-the-counter ranitidine drugs from the market due to a cancer-causing risk.
Zantac (ranitidine) is a popular drug used to treat heartburn, ulcers of the stomach and intestines, and other problems. More than 15 million people have Zantac prescriptions, and many more use over-the-counter ranitidine medications.
Preliminary testing in 2019 revealed the presence of the carcinogen N-Nitrosodimethylamine (NDMA) in Zantac and other ranitidine medications. But an ongoing investigation found that levels of NDMA increase over time within the medication and as temperatures increase. The FDA noted that consumers should stop taking over-the-counter ranitidine medications and that patients with ranitidine prescriptions should speak with their health care provider about other treatment options before stopping.
Cancer Diagnoses in Zantac Users
Some people who have routinely used Zantac and other ranitidine medications have been diagnosed with cancer. The primary types of cancer linked to Zantac use include:
- Esophageal / Throat / Nose
- Multiple Myeloma
- Non Hodgkin’s Lymphoma
If you were diagnosed with cancer after taking Zantac routinely for at least a year, you may be able to join litigation to hold the manufacturer accountable. Please complete the questionnaire here, and we will contact you to discuss your situation. All your information will be kept private.
Zantac Drug Lawsuit Information
Millions of people who took the heartburn drug Zantac and its generic ranitidine were unknowingly exposed to the carcinogen N-Nitrosodimethylamine (NDMA). Those who have developed cancer are now seeking justice and damages from the maker of Zantac, who failed to adequately test the drug or warn the public of the cancer risks.
For those who routinely took Zantac, unaware of its risk, the news of a connection to cancer could be devastating – especially for those who have been diagnosed.
In February 2020, multidistrict litigation (MDL) was filed in South Florida court on behalf of people who were diagnosed with cancer after taking Zantac. Multidistrict litigation refers to a gathering of several cases into one court when they cover similar issues. Fifteen plaintiffs were consolidated into the MDL. More than 100 Zantac lawsuits are pending nationwide.
As one of the longest-existing law firms in California, CaseyGerry has spent decades taking companies to task when their careless conduct cause injury. Our attorneys have spearheaded high-profile litigation against some of the largest corporations in the world, including many drug companies. No defendant is too big for us.
If you have been diagnosed with cancer after taking Zantac regularly for at least a year prior to your cancer diagnosis, you may be able to join the litigation against the maker of the drug. We can explain your options for seeking damages and the next steps to file a claim. Please complete the questionnaire, and we will contact you to discuss your case. All your information will be kept private. There is no obligation when you speak with our firm
The personal injury lawyers at CaseyGerry have been successfully representing injured plaintiffs for more than 70 years. Our adversaries have ranged from negligent individuals to some of the largest corporations in the world.
Our firm has represented individual clients as well as large groups after they were harmed by a person or company’s careless behavior.